Strategic Marginality

in The Cuban Cure

Published by University of Chicago Press

Published in print December 2010 | ISBN: 9780226709178
Published online March 2013 | e-ISBN: 9780226709192 | DOI:
Strategic Marginality

Show Summary Details


This chapter focuses on the marginalization of Cuba's biotechnology sector. It explains that Cuba had problems in intellectual property rights and that the tightening of the U.S. embargo negatively affected the supply of basic scientific materials. It discusses the dual regulation of Cuba as a specifically disenfranchised site within the US-dominated geography of global pharmaceutical production. This chapter also mentions that U.S. Undersecretary of State John Bolton accused Cuba's biotechnology industry of producing biological weapons in 2002.

Keywords: biotechnology; Cuba; intellectual property rights; U.S. embargo; scientific materials; dual regulation; pharmaceutical production; John Bolton; biological weapons

Chapter.  10268 words. 

Subjects: History of Science and Technology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.